Skip to content

Journal Highlights: content uniformity of busulfan capsulese

A practice article was recently published in the European Journal of Hospital Pharmacyon the determination of content uniformity of busulfan capsules by liquid chromatography-mass spectrometry.
Oral high dose busulfan (1,4-butanediol dimethanesulfonate) is frequently used in conditioning regimens prior to haematopoietic stem cell transplantation. As tablets with high dose busulfan are not commercially available, it is common practice to extemporaneously prepare capsules in hospital pharmacies.

In the study, described in the Journal, an HPLC–mass spectrometry (MS) method that was previously validated for quantification of plasma levels of busulfan was adapted for determination of the content uniformity of capsules comprising 50 mg of busulfan for high dose regimens.

The results found intraday and interday variability and imprecision were less than 2.2% indicating high specificity and sensitivity of this novel assay.

The full text of the research article is available of the EJHP website here

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.